STRYKER CORP

Key metrics

Financial performance

Over the last 9 fiscal years STRYKER CORP's revenue grew from $11.32B to $25.12B, a compound annual growth rate of 9.3%. Net profit margin compressed from 14.5% to 12.9% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (1,000 filings)

Recent press releases

• Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio2026-05-07

  “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.”

• Stryker declares an $0.88 per share quarterly dividend2026-05-07

  Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

• Stryker To Participate In The Bank Of America Securities 2026 Global Healthcare Conference2026-05-01

  Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference

• Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio2026-04-13

  The acquisition will strengthen Stryker’s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker’s existing PV offerings and support the company’s strategy to expand its presence in arterial disease treatment.

• Stryker to announce financial results for its first quarter of fiscal year 20262026-04-01

  Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Similar companies

The largest companies sharing STRYKER CORP's SEC industry classification (surgical & medical instruments & apparatus).